1.
Gang An, Yan Xu, Lihui Shi, Zhong Shizhen, Shuhui Deng, Zhenqing Xie, Weiwei Sui, Fenghuang Zhan, Lugui Qiu. Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value. haematol [Internet]. 2014Feb.1 [cited 2022Jun.30];99(2):353-9. Available from: https://haematologica.org/article/view/6936